Libero
MAIL
NEWS
SPORT
VIDEO
COMMUNITY
IN CITTÀ
ALTRO
BLOG
CHAT
DILEI
BUONISSIMO
SIVIAGGIA
24X7
TUTTI I SERVIZI
AIUTO
Griglia
Timeline
Grafo
Prima pagina
Lombardia
Veneto
Piemonte
Lazio
Sicilia
Sardegna
Emilia Romagna
Campania
Puglia
Calabria
Regione Selezionata
Altre regioni
Toscana
Umbria
Abruzzo
Basilicata
Friuli Venezia Giulia
Liguria
Marche
Molise
Trentino-Alto Adige
Valle D'Aosta
Cronaca
Economia
Mondo
Politica
Spettacoli e Cultura
Sport
Scienza e Tecnologia
Stampa estera
Informazione locale
egpa
Ordina per:
Più recente
Più letto
Egpa, un nuovo farmaco per i malati
...//www.lastampa.it/salute/dossier/frontiere/2026/05/22/video/
egpa
_un_nuovo_farmaco_per_i_malati - 425363338/ Embed
La Stampa</a> - <span class="news_blogs_datetime">22-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Persone:</span><a href="/dsearch/jan+w.+schroeder/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">jan w. schroeder</a><a href="/dsearch/daniele+alberti/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">daniele alberti</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Organizzazioni:</span><a href="/dsearch/aifa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">aifa</a><a href="/dsearch/irccs/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">irccs</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a><a href="/dsearch/malati/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">malati</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 1px solid #cccccc" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=27e39b0ce6c49f6414b87a60feac69e8&rg=7&sq=1&wb=68327506&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68327506%2F22%2Fegpa-fede-astrazeneca-benralizumab-riduce-anche-uso-corticosteroidi%2F&','news')" href="/focus/68327506/22/egpa-fede-astrazeneca-benralizumab-riduce-anche-uso-corticosteroidi/">Egpa, Fede (AstraZeneca): 'Benralizumab riduce anche uso corticosteroidi'</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: Adnkronos" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=27e39b0ce6c49f6414b87a60feac69e8&rg=7&sq=1&wb=68327506&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68327506%2F22%2Fegpa-fede-astrazeneca-benralizumab-riduce-anche-uso-corticosteroidi%2F&','news')" target="_blank" href="/focus/68327506/22/egpa-fede-astrazeneca-benralizumab-riduce-anche-uso-corticosteroidi/"><img src="https://img.plug.it/img_news/6/0/5/68327506.jpg" alt="Fonte della foto: Adnkronos" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;">'In studio Mandara remissione per 58% dei soggetti'</div> <a class="normalLink" target="_blank" href="http://www.adnkronos.com" style="font-size:11px">Adnkronos</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Organizzazioni:</span><a href="/dsearch/astrazeneca/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">astrazeneca</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a><a href="/dsearch/benralizumab/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">benralizumab</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 1px solid #cccccc" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=83c4cdb77cc564b2e7a444e4607c34ca&rg=7&sq=1&wb=68324616&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68324616%2F22%2Fegpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita%2F&','news')" href="/focus/68324616/22/egpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita/">Egpa, reumatologa Monti: 'Benralizumab cura mirata migliora qualit di vita'</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: Adnkronos" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=83c4cdb77cc564b2e7a444e4607c34ca&rg=7&sq=1&wb=68324616&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68324616%2F22%2Fegpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita%2F&','news')" target="_blank" href="/focus/68324616/22/egpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita/"><img src="https://img.plug.it/img_news/6/1/6/68324616.jpg" alt="Fonte della foto: Adnkronos" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;">'Potenziali conseguenze molto gravi, sia riconosciuta tempestivamente'</div> <a class="normalLink" target="_blank" href="http://www.adnkronos.com" style="font-size:11px">Adnkronos</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Persone:</span><a href="/dsearch/benralizumab/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">benralizumab</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a><a href="/dsearch/monti/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">monti</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 1px solid #cccccc" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=344303d3f188bb3595956bdc8d2a6824&rg=7&sq=1&wb=68324615&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68324615%2F22%2Fegpa-durante-apacs-terapie-aiutano-lavorare-su-presa-in-carico%2F&','news')" href="/focus/68324615/22/egpa-durante-apacs-terapie-aiutano-lavorare-su-presa-in-carico/">Egpa, Durante (Apacs): 'Terapie aiutano, lavorare su presa in carico'</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: Adnkronos" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=344303d3f188bb3595956bdc8d2a6824&rg=7&sq=1&wb=68324615&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68324615%2F22%2Fegpa-durante-apacs-terapie-aiutano-lavorare-su-presa-in-carico%2F&','news')" target="_blank" href="/focus/68324615/22/egpa-durante-apacs-terapie-aiutano-lavorare-su-presa-in-carico/"><img src="https://img.plug.it/img_news/5/1/6/68324615.jpg" alt="Fonte della foto: Adnkronos" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;">'Associazioni necessarie per creare network e intercettare i bisogni degli assistiti'</div> <a class="normalLink" target="_blank" href="http://www.adnkronos.com" style="font-size:11px">Adnkronos</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Persone:</span><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Prodotti:</span><a href="/dsearch/terapie/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">terapie</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/apacs/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">apacs</a><a href="/dsearch/associazioni+necessarie/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">associazioni necessarie</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 1px solid #cccccc" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=6f7cf18d6a06ab7aaba9e87b0440f00b&rg=7&sq=1&wb=68324490&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68324490%2F22%2Fmalattie-rare-egpa-recidivante-o-refrattaria-si-ampliano-indicazioni-per-anti-il-5%2F&','news')" href="/focus/68324490/22/malattie-rare-egpa-recidivante-o-refrattaria-si-ampliano-indicazioni-per-anti-il-5/">Malattie rare: Egpa recidivante o refrattaria, si ampliano indicazioni per anti Il - 5</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: Adnkronos" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=6f7cf18d6a06ab7aaba9e87b0440f00b&rg=7&sq=1&wb=68324490&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68324490%2F22%2Fmalattie-rare-egpa-recidivante-o-refrattaria-si-ampliano-indicazioni-per-anti-il-5%2F&','news')" target="_blank" href="/focus/68324490/22/malattie-rare-egpa-recidivante-o-refrattaria-si-ampliano-indicazioni-per-anti-il-5/"><img src="https://img.plug.it/img_news/0/9/4/68324490.jpg" alt="Fonte della foto: Adnkronos" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;">AstraZeneca: 'Con benralizumab in granulomatosi eosinofila con poliangite remissione clinica in 58% pazienti e riduzione dipendenza da corticosteroidirali in 80%'</div> <a class="normalLink" target="_blank" href="http://www.adnkronos.com" style="font-size:11px">Adnkronos</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Organizzazioni:</span><a href="/dsearch/astrazeneca/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">astrazeneca</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/malattie+rare/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">malattie rare</a><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 1px solid #cccccc" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=7d4ef6ff27245f251d30d67fb2be3573&rg=7&sq=1&wb=68324535&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68324535%2F22%2Fgranulomatosi-eosinofila-con-poliangite-ok-dell-aifa-a-nuova-terapia%2F&','news')" href="/focus/68324535/22/granulomatosi-eosinofila-con-poliangite-ok-dell-aifa-a-nuova-terapia/">Granulomatosi eosinofila con poliangite, ok dell'Aifa a nuova terapia</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: La Stampa" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=7d4ef6ff27245f251d30d67fb2be3573&rg=7&sq=1&wb=68324535&ml=1&uc=http%3A%2F%2F247.libero.it%2Ffocus%2F68324535%2F22%2Fgranulomatosi-eosinofila-con-poliangite-ok-dell-aifa-a-nuova-terapia%2F&','news')" target="_blank" href="/focus/68324535/22/granulomatosi-eosinofila-con-poliangite-ok-dell-aifa-a-nuova-terapia/"><img src="https://img.plug.it/img_news/5/3/5/68324535.jpg" alt="Fonte della foto: La Stampa" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;"> I dati del primo studio comparativo tra farmaci biologici nelle persone con <b>EGPA</b> hanno dimostrato che il 58% dei pazienti trattati con questa nuova terapia ha raggiunto la remissione clinica, e una ...</div> <a class="normalLink" target="_blank" href="http://www.lastampa.it" style="font-size:11px">La Stampa</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Persone:</span><a href="/dsearch/irma+d'aria/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">irma d'aria</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Organizzazioni:</span><a href="/dsearch/aifa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">aifa</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Prodotti:</span><a href="/dsearch/terapie/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">terapie</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Luoghi:</span><a href="/dsearch/italia/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">italia</a><a href="/dsearch/europa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">europa</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/eosinofila/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">eosinofila</a><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 1px solid #cccccc" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=3ee182474dfd72480d8ae7cd8219786f&rg=7&sq=1&wb=56672158&ml=1&uc=http%3A%2F%2F247.libero.it%2Frfocus%2F56672158%2F22%2Fegpa-fede-astrazeneca-benralizumab-riduce-anche-uso-corticosteroidi%2F&','news')" href="/rfocus/56672158/22/egpa-fede-astrazeneca-benralizumab-riduce-anche-uso-corticosteroidi/">Egpa, Fede (AstraZeneca): "Benralizumab riduce anche uso corticosteroidi"</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: AostaCronaca.it" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=3ee182474dfd72480d8ae7cd8219786f&rg=7&sq=1&wb=56672158&ml=1&uc=http%3A%2F%2F247.libero.it%2Frfocus%2F56672158%2F22%2Fegpa-fede-astrazeneca-benralizumab-riduce-anche-uso-corticosteroidi%2F&','news')" target="_blank" href="/rfocus/56672158/22/egpa-fede-astrazeneca-benralizumab-riduce-anche-uso-corticosteroidi/"><img src="https://img.plug.it/img_newsreg/8/5/1/56672158.jpg" alt="Fonte della foto: AostaCronaca.it" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;"> Grazie allo studio Mandara e all'indicazione delle <b>Egpa</b>, possiamo affermare il valore clinico e scientifico in termini sia di efficacia che di sicurezza di benralizumab in questi ambiti". La stessa ...</div> <a class="normalLink" target="_blank" href="http://www.valledaostaglocal.it" style="font-size:11px">AostaCronaca.it</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Persone:</span><a href="/dsearch/raffaella+fede/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">raffaella fede</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Organizzazioni:</span><a href="/dsearch/astrazeneca/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">astrazeneca</a><a href="/dsearch/aifa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">aifa</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Luoghi:</span><a href="/dsearch/italia/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">italia</a><a href="/dsearch/milano/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">milano</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/benralizumab/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">benralizumab</a><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 1px solid #cccccc" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=c6a91fddabc7248497a33be811246020&rg=7&sq=1&wb=56672644&ml=1&uc=http%3A%2F%2F247.libero.it%2Frfocus%2F56672644%2F22%2Fegpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita%2F&','news')" href="/rfocus/56672644/22/egpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita/">Egpa, reumatologa Monti: 'Benralizumab cura mirata migliora qualità di vita'</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: Sardegna News" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=c6a91fddabc7248497a33be811246020&rg=7&sq=1&wb=56672644&ml=1&uc=http%3A%2F%2F247.libero.it%2Frfocus%2F56672644%2F22%2Fegpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita%2F&','news')" target="_blank" href="/rfocus/56672644/22/egpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita/"><img src="https://img.plug.it/img_newsreg/4/4/6/56672644.jpg" alt="Fonte della foto: Sardegna News" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;"> Così Sara Monti, responsabile Uo Immunologia, allergologia e reumatologia, Istituto Auxologico Italiano di Milano, intervenendo oggi all'incontro con la stampa su '<b>Egpa</b> - Granulomatosi eosinofila con ...</div> <a class="normalLink" target="_blank" href="http://sardanews.it" style="font-size:11px">Sardegna News</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Persone:</span><a href="/dsearch/uo+immunologia/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">uo immunologia</a><a href="/dsearch/sara+monti/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">sara monti</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Organizzazioni:</span><a href="/dsearch/istituto+auxologico+italiano/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">istituto auxologico italiano</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Prodotti:</span><a href="/dsearch/terapie/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">terapie</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Luoghi:</span><a href="/dsearch/milano/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">milano</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a><a href="/dsearch/benralizumab/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">benralizumab</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 1px solid #cccccc" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=0e69eeaeb69530b7c03e9997a9921702&rg=7&sq=1&wb=56672533&ml=1&uc=http%3A%2F%2F247.libero.it%2Frfocus%2F56672533%2F22%2Fegpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita%2F&','news')" href="/rfocus/56672533/22/egpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita/">Egpa, reumatologa Monti: "Benralizumab cura mirata migliora qualità di vita"</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: Sanremo news.it" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=0e69eeaeb69530b7c03e9997a9921702&rg=7&sq=1&wb=56672533&ml=1&uc=http%3A%2F%2F247.libero.it%2Frfocus%2F56672533%2F22%2Fegpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita%2F&','news')" target="_blank" href="/rfocus/56672533/22/egpa-reumatologa-monti-benralizumab-cura-mirata-migliora-qualit-di-vita/"><img src="https://img.plug.it/img_newsreg/3/3/5/56672533.jpg" alt="Fonte della foto: Sanremo news.it" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;"> Così Sara Monti, responsabile Uo Immunologia, allergologia e reumatologia, Istituto Auxologico Italiano di Milano, intervenendo oggi all'incontro con la stampa su '<b>Egpa</b> - Granulomatosi eosinofila con ...</div> <a class="normalLink" target="_blank" href="http://www.sanremonews.it" style="font-size:11px">Sanremo news.it</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Persone:</span><a href="/dsearch/sara+monti/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">sara monti</a><a href="/dsearch/uo+immunologia/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">uo immunologia</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Organizzazioni:</span><a href="/dsearch/istituto+auxologico+italiano/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">istituto auxologico italiano</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Prodotti:</span><a href="/dsearch/terapie/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">terapie</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Luoghi:</span><a href="/dsearch/milano/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">milano</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a><a href="/dsearch/benralizumab/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">benralizumab</a> </div> </div></td> </tr></table> </td></tr> <tr><td style="width:100%;border-bottom: 0px" colspan="1" align="left"> <div style="width: 100%; margin: 5px 0px 3px 0px;; clear: both;overflow: hidden; padding: 0;"><a class="normalLink" style=" font-size: 16px; font-weight: bold; " onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=5b3b164dafa40a301279fed3321807e9&rg=7&sq=1&wb=56672138&ml=1&uc=http%3A%2F%2F247.libero.it%2Frfocus%2F56672138%2F22%2Fegpa-durante-apacs-terapie-aiutano-lavorare-su-presa-in-carico%2F&','news')" href="/rfocus/56672138/22/egpa-durante-apacs-terapie-aiutano-lavorare-su-presa-in-carico/">Egpa, Durante (Apacs): "Terapie aiutano, lavorare su presa in carico"</a></div> <table cellpadding="0" cellspacing="0" border="0" style="margin-top:7px;"><tr> <td style="width:130px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="margin:0px 10px 0px 0px;width:155px;height:95px;overflow:hidden; ;"><a title="Fonte della foto: Ossola News" onmousedown="return ajaxTrace(this,event,'/cgi-bin/ajaxTrace?id=115&pg=1&qi=2000-01-01-00:00:00&wu=-1&wl=-1&nf=-1&ct=0&ip=X&nl=-1&m=5b3b164dafa40a301279fed3321807e9&rg=7&sq=1&wb=56672138&ml=1&uc=http%3A%2F%2F247.libero.it%2Frfocus%2F56672138%2F22%2Fegpa-durante-apacs-terapie-aiutano-lavorare-su-presa-in-carico%2F&','news')" target="_blank" href="/rfocus/56672138/22/egpa-durante-apacs-terapie-aiutano-lavorare-su-presa-in-carico/"><img src="https://img.plug.it/img_newsreg/8/3/1/56672138.jpg" alt="Fonte della foto: Ossola News" border="0" width="155px"></a></div></td> <td valign="top" style="padding-bottom:10px;padding-top:0px;width:285px;"> <div class="normalText" style="margin-top:-2px;clear:both;margin-bottom:5px;font-size:12px;"> "I sintomi iniziali di <b>Egpa</b> sono molto simili a patologie comuni come l'asma cronica - spiega Durante - per questo la diagnosi può impiegare anni e comportare una frustrazione eccessiva sul paziente,...</div> <a class="normalLink" target="_blank" href="http://www.ossolanews.it" style="font-size:11px">Ossola News</a> - <span class="news_blogs_datetime">20-5-2026</span> </td> <td style="width:150px;padding-bottom:10px;padding-top:0px;" valign="top"><div style="width:160px;margin-left:15px;padding-left:15px;border-left: 1px solid #cccccc;padding-bottom:18px"> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Persone:</span><a href="/dsearch/richard+strauss/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">richard strauss</a><a href="/dsearch/eugenia+durante/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">eugenia durante</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Organizzazioni:</span><a href="/dsearch/apacs/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">apacs</a><a href="/dsearch/aifa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">aifa</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Prodotti:</span><a href="/dsearch/terapie/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">terapie</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Luoghi:</span><a href="/dsearch/milano/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">milano</a> </div> <div style="width:159px;font-size:11px;clear:both;" class="normalText normalFont"> <span style="clear:left;float:left;margin:2px 0px">Tags:</span><a href="/dsearch/egpa/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">egpa</a><a href="/dsearch/patologia+rara/" class="normalLink" style="float:left;white-space:nowrap;margin:2px 0px 2px 2px;font-size:11px; ">patologia rara</a> </div> </div></td> </tr></table> </td></tr> </table> </div></td></tr></table></div></td><td style="width:34%" valign="top" align="left"><div xmlns="" id="body_col3_share_links" style="margin-bottom: 10px;"><div id="col_3_share_links" style="float:left;text-align:left"> <div class="ssocial"> <div style="color:#0d5c9c;font-weight:bold;margin-bottom:8px;margin-top:0px;clear:both;padding-top:0px;width:100%"><div style="margin:0px;float:left;clear:right;width:100%;margin-top:5px;margin-bottom:5px;"><span class="blueText" style="color:#000;margin-left:10px;">CONDIVIDI QUESTA PAGINA SU</span></div></div> <a class="fb" href="#" id="fbShare" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u='+encodeURIComponent(location.href), 'facebook-share-dialog', 'width=450,height=420,top=300,left=300'); return false;" style="margin-left:8px;">Facebook</a><a class="tw" href="#" id="twShare" onclick="window.open('https://twitter.com/home?status='+encodeURIComponent(location.href), 'twitter-dialog', 'width=450,height=420,top=300,left=300'); return false;" target="_blank">Twitter</a><a class="send" href="#" id="sendShare" onclick="send_to_a_friend(); return false;">Invia</a><script type="text/javascript"> var send_to_a_friend = function() { jQuery.ajax({ async: false, url: '/cgi-bin/stf.cgi?object=' + encodeURIComponent(document.title) + '&id=247&url=' + encodeURIComponent(location.href), success: function (out) { window.open(out,'send','width=440,height=500,status=no,toolbar=no,resizable=no,scrollbars=no,top=120,left=150').focus(); }, error: function (out) {} }); } </script><a class="rss" href="?rs=1" id="rssShare" target="_blank">RSS</a> </div> <div class="col_3_news_cls" style="height:40px;border:0px;padding-top:10px;"><div style="margin:0px 9px"><div class="facebook-pl"> <fb:like ref="facebook_ref"></fb:like><iframe src="http://www.facebook.com/plugins/like.php?href=http%3A%2F%2F247.libero.it%2Fsearch%2Fegpa%2F&layout=standard&show_faces=false&width=280&action=like&font&colorscheme=light&height=80&locale=it_IT&ref=facebook_ref" scrolling="no" frameborder="0" style="border:none; overflow:hidden; width:280px; height:60px;" allowTransparency="true">
Termini e condizioni d'uso - Contattaci
Conosci Libero Mail?
Sai che Libero ti offre una mail gratis con 5GB di spazio cloud su web, cellulare e tablet?
Scopri di più
CITTA'
Milano
Roma
Napoli
Bologna
Venezia
Torino
Bari
Palermo
Firenze
Genova
Catanzaro
Ancona
Trieste
L'Aquila
Perugia
Cagliari
Trento
Potenza
Campobasso
Aosta
Altre città
FOTO
Egpa, il ritardo nella diagnosi l'ostacolo più grande
La Stampa
-
20-5-2026
Egpa, un nuovo farmaco per i malati
La Stampa
-
20-5-2026
Egpa, reumatologa Monti: 'Benralizumab cura mirata migliora qualità di vita'
OglioPo News
-
20-5-2026
Egpa, Durante (Apacs): 'Terapie aiutano, lavorare su presa in carico'
Sardegna News
-
20-5-2026
1 di 2
Egpa, Fede (AstraZeneca): 'Benralizumab riduce anche uso corticosteroidi'
Sardegna News
-
20-5-2026
Granulomatosi eosinofila con poliangite, ok dell'Aifa a nuova terapia
La Stampa
-
20-5-2026
Malattie rare: Egpa recidivante o refrattaria, si ampliano indicazioni per anti Il - 5
Adnkronos
-
20-5-2026
2 di 2
Gli articoli sono stati selezionati e posizionati in questa pagina in modo automatico. L'ora o la data visualizzate si riferiscono al momento in cui l'articolo è stato aggiunto o aggiornato in Libero 24x7
